A case report of drug-induced thrombocytopenia after living donor liver transplantation

Kobe Journal of Medical Sciences

Volumn 62, Issue 1, 2016, Pages E9-E12

  Arai, Keisuke ^a   Kuramitsu, Kaori ^a   Fukumoto, Takumi ^a   Kido, Masahiro ^a   Takebe, Atsushi ^a   Tanaka, Motofumi ^a   Kinoshita, Hisoka ^a   Ajiki, Tetsuo ^a   Toyama, Hirochika ^a   Asari, Sadaki ^a   Goto, Tadahiro ^a   Ku, Yonson ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Direct acting antiviral drugs; Drug induced thrombocytopenia; Living donor liver transplantation; Tacrolimus

Indexed keywords

ANTIBIOTIC AGENT; ASUNAPREVIR; CYCLOSPORIN; DACLATASVIR; FRESH FROZEN PLASMA; STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED THROMBOCYTOPENIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR LIVER TRANSPLANTATION; MIDDLE AGED; PLASMA TRANSFUSION; PYELONEPHRITIS; SEPSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS LOAD; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; LIVING DONOR; THROMBOCYTE COUNT;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; TACROLIMUS; THROMBOCYTOPENIA;

EID: 84975109017     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Martinez-Pascual, C., Martinez-Caselles, A., Anton-Rodenas, G, et al. 2012 Severe thrombocytopenia in liver transplantation. Rev Esp Enferm Dig 104(5): 280-282.
2. Chin, J.L., Hisamuddin, S.H., O’Sullivan, A., et al. 2014 Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation. Clin Appl Thromb Hemost 10.1177/107602961455977110.1177/1076029614559771
3. Akamatsu, N., Sugawara, Y., Tamura, S., et al. 2007 Late mortality from thrombotic microangiopathy after liver transplantation: report of a case. Surg Today 37(4): 345-348. 10.1007/s00595-006-3394-3
4. Matsuda, D., Toshima, T., Ikegami, T., et al. 2014 Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case. Clin J Gastroenterol 7(2): 159-163. 10.1007/s12328-013-0446-2
5. Pannicke, N., Pollok, J.M., Kluge, S., et al. 2012 Heparin-induced thrombocytopenia associated with acute liver graft failure. BMJ Case Rep 2012(10.1136/bcr-2012-007323
6. Aster, R.H. and Bougie, D.W. 2007 Drug-induced immune thrombocytopenia. N Engl J Med;357(6): 580-587. 10.1056/NEJMra066469
7. van den Bemt, P.M., Meyboom, R.H. and Egberts, A.C. 2004 Drug-induced immune thrombocytopenia. Drug Saf 27(15): 1243-1252.
8. Curtis, B.R. 2014 Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology 30(2): 55-65.
9. Diaz, GC., Prowda, J., Lo, I.J., et al. 2008 Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors. Liver Transpl 14(12): 1803-1809. 10.1002/lt.21539
10. Taylor, R.M., Bockenstedt, P., Su, GL., et al. 2006 Immune thrombocytopenic purpura following liver transplantation: a case series and review of the literature. Liver Transpl 12(5): 781-791. 10.1002/lt.20715
11. de la Torre, A.N., Fisher, A., Wilson, D.J., et al. 2004 A case report of donor to recipient transmission of severe thrombocytopenia purpura. Transplantation 77(9): 1473-1474.
12. George, J.N., Raskob, GE., Shah, S.R., et al. 1998 Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 129(11): 886-890.
13. George, J.N. and Aster, R.H. 2009 Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program 10.1182/asheducation-2009.1.153: 153-158. 10.1182/asheducation-2009.1.153
14. Pedersen-Bjergaard, U., Andersen, M. and Hansen, P.B. 1998 Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs. Eur J Clin Pharmacol 54(9-10): 701-706.
15. Warkentin, T.E. 2007 Drug-induced immune-mediated thrombocytopenia--from purpura to thrombosis. N Engl J Med 356(9): 891-893. 10.1056/NEJMp068309
16. Roche, B., Coilly, A., Roque-Afonso, A.M., et al. 2015 Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance. Viruses 7(9): 5155-5168. 10.3390/v7092864
17. Kumada, H., Suzuki, Y., Ikeda, K., et al. 2014 Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 59(6): 2083-2091. 10.1002/hep.27113
18. Cholongitas, E., Pipili, C. and Papatheodoridis, G 2015 Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients. World J Gastroenterol 21(32): 9526-9533. 10.3748Avjg.v21.i32.9526